Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 21.27 USD -0.89% Market Closed
Market Cap: 2.5B USD
Have any thoughts about
Catalyst Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

CPRX Price Targets Summary
Catalyst Pharmaceuticals Inc

Wall Street analysts forecast CPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPRX is 32.9 USD with a low forecast of 28.28 USD and a high forecast of 39.9 USD.

Lowest
Price Target
28.28 USD
33% Upside
Average
Price Target
32.9 USD
55% Upside
Highest
Price Target
39.9 USD
88% Upside
Catalyst Pharmaceuticals Inc Competitors:
Price Targets
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
17% Upside
NTRA
Natera Inc
14% Upside
MGX
Metagenomi Inc
363% Upside
206650
EuBiologics Co Ltd
37% Upside
IFRX
InflaRx NV
292% Upside
MAAT
Maat Pharma SA
109% Upside
CCCC
C4 Therapeutics Inc
317% Upside
ITOS
Iteos Therapeutics Inc
244% Upside

Revenue
Forecast

Revenue Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 4 years is 16%.

N/A
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 4 years is 41%.

N/A
Past Growth
41%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 4 years is 49%.

N/A
Past Growth
49%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPRX's stock price target?
Price Target
32.9 USD

According to Wall Street analysts, the average 1-year price target for CPRX is 32.9 USD with a low forecast of 28.28 USD and a high forecast of 39.9 USD.

What is Catalyst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
16%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 4 years is 16%.

What is Catalyst Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
41%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 4 years is 41%.

What is Catalyst Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
49%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 4 years is 49%.

Back to Top